Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells.
Wathikthinnakon M, Luangwattananun P, Sawasdee N, Chiawpanit C, Lee VS, Nimmanpipug P, Tragoolpua Y, Rotarayanont S, Sangsuwannukul T, Phanthaphol N, Wutti-In Y, Somboonpatarakun C, Chieochansin T, Junking M, Sujjitjoon J, Yenchitsomanus PT, Panya A.
Wathikthinnakon M, et al. Among authors: wutti in y.
Sci Rep. 2022 Apr 13;12(1):6154. doi: 10.1038/s41598-022-09964-6.
Sci Rep. 2022.
PMID: 35418130
Free PMC article.